Filter by: patients
Home > Community Treatment Reports and Side Effects > Ipratropium-Albuterol Treatment Report
What is Ipratropium-Albuterol?

Ipratropium and albuterol (salbutamol) is a bronchodilator that combine ipratropium bromide and albuterol sulfate (salbutamol) and is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is available in a nebulizer solution and as an inhalant.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Asthma 22 2 Efficacy_major Efficacy_moderate
COPD (Chronic Obstructive Pulmonary Disease) 13 0
Other 9 0
Breathing difficulty 8 1 Efficacy_major
ALS (Amyotrophic Lateral Sclerosis) 4 1 Efficacy_moderate
Asthma 4 1 Efficacy_slight

See all 73 patients currently taking Ipratropium-Albuterol

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 1
None
 8

Commonly reported side effects, conditions, and hospitalizations associated with Ipratropium-Albuterol

Cramps in biceps 1
Claw-like cramps in hands 1

Reported Dosages

Frequently reported dosages based on patients currently taking Ipratropium-Albuterol. See all 37 dosages ►

  90mcg-18mcg/inh as needed 3ml as needed 2 90mcg-18mcg/inh as needed 2.5mg-0.5mg/3mL as needed 1other as needed 4 other daily 90 mcg-18 mcg/inh daily 2 x 90 mcg-18 mcg/inh daily 3 x 90 mcg-18 mcg/inh daily 4 x 90 mcg-18 mcg/inh daily
  10 Number of Patients: 10 3 Number of Patients: 3 5 Number of Patients: 5 4 Number of Patients: 4 4 Number of Patients: 4 3 Number of Patients: 3 8 Number of Patients: 8 5 Number of Patients: 5 3 Number of Patients: 3 6 Number of Patients: 6  

Reported Stop Reasons

Why Patients Stopped Taking Ipratropium-Albuterol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 2   Course of treatment ended: 33%
Doctor's advice 1   Doctor's advice: 17%
Other 1   Other: 17%
Change in health plan coverage 1   Change in health plan coverage: 17%
Not indicated 1   Not indicated: 17%

See all 6 patients who’ve stopped taking Ipratropium-Albuterol

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Ipratropium-Albuterol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Ipratropium-Albuterol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Ipratropium-Albuterol

Always
 7 70%
Usually
 2 20%
Sometimes
 0 0%
Never
 1 10%

Burden

Difficulty being on treatment

Burden of Ipratropium-Albuterol

Very
 0 0%
Somewhat
 3 30%
A little
 1 10%
Not at all
 6 60%

Cost

Paid out of pocket

Cost of Ipratropium-Albuterol

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 1 14%
< $25
 6 86%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.